Trials / Unknown
UnknownNCT02553278
VelaShape and Contour I V3 for Abdominal Fat Reduction vs. Control
Clinical Study to Evaluate the Performances of Modified VelaShape and the Performance of Contour I V3 Devices for Abdominal Fat Reduction vs. Control
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Syneron Medical · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Prospective, 2-arm, clinical study for the evaluation of the VelaShape device and Contour I V3 device for non-invasive fat reduction vs. control. All study subjects, who are scheduled for abdominoplasty, will undergo one treatment with VelaShape or Contour I V3 device. Each arm will be treated with a different device: Arm 1: subject will treated with VelaShape device Arm 2: subject will treated with Contour I V3 device
Detailed description
Eligible subjects will undergo one treatment on one abdominal subarea. Another abdominal subarea will remain without treatment and will serve as a control. Biopsies from treated and untreated areas will be harvested during abdominoplasty and cultured.. Treatment with VelaShape will be performed to arm 1, and treatment with Contour I V3 will be performed to arm 2, according to the study protocol. Each arm will be divided into 6 sub-groups, according to the following time interval between VelaShape or UltraShape treatment to surgery: Sub-group 1: Surgery immediately after treatment Sub-group 2: Surgery 10 days after treatment Sub-group 3: Surgery 20 days after treatment Sub-group 4: Surgery 30 days after treatment Sub-group 5: Surgery 60 days after treatment Sub-group 6: Surgery 90 days after treatment Each Sub-group contains up to 2 subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VelaShape device | Modified VelaShape radiofrequency device for non invasive fat reduction treatment. |
| DEVICE | Contour I V3 device | Contour I V3 device are non invasive for fat reduction. |
Timeline
- Start date
- 2016-01-10
- Primary completion
- 2017-10-01
- Completion
- 2017-12-01
- First posted
- 2015-09-17
- Last updated
- 2017-04-10
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02553278. Inclusion in this directory is not an endorsement.